Compounds > cobalt
Page last updated: 2024-08-26

cobalt and Parkinson Disease, Secondary

cobalt has been researched along with Parkinson Disease, Secondary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chai, ZF; Chen, J; Hu, Y; Lan, AP1
Aguilar, MV; Arrieta, FJ; Ayuso-Peralta, L; Cabrera-Valdivia, F; García-Albea, E; Jiménez-Jiménez, FJ; Jorge-Santamaría, A; Molina, JA; Rabasa, M; Vázquez, A1

Reviews

1 review(s) available for cobalt and Parkinson Disease, Secondary

ArticleYear
The neurotoxicity of iron, copper and cobalt in Parkinson's disease through ROS-mediated mechanisms.
    Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2016, Volume: 29, Issue:4

    Topics: Cobalt; Copper; DNA Damage; Humans; Iron; Oxidative Stress; Parkinson Disease; Parkinson Disease, Secondary; Reactive Oxygen Species

2016

Other Studies

1 other study(ies) available for cobalt and Parkinson Disease, Secondary

ArticleYear
Serum and urinary manganese levels in patients with Parkinson's disease.
    Acta neurologica Scandinavica, 1995, Volume: 91, Issue:5

    Topics: Activities of Daily Living; Aged; Brain; Chromium; Cobalt; Female; Humans; Lipid Peroxidation; Male; Manganese; Metabolic Clearance Rate; Parkinson Disease; Parkinson Disease, Secondary; Receptors, Dopamine; Risk Factors

1995